1/12/20
ISSNAF Stories
Life Sciences
Medicine
Patrizia Mondello
Advanced Oncology Fellow
Memorial Sloan Kettering Cancer Center

2020 ISSNAF Young Investigaror Paola Campese Award
Advancing Targeted Therapies and Precision Medicine in B-Cell Lymphomas.
Dr. Patrizia Mondello is an Advanced Oncology Fellow at Memorial Sloan Kettering Cancer Center (MSKCC), specializing in the biology and treatment of B-cell lymphoma. With training in Medical Oncology and a PhD in Cellular Biology, she has developed novel therapies targeting oncogenic pathways such as PI3K, BCL2, and NF-kB. Her research on CUDC-907 helped secure FDA approval for relapsed B-cell lymphoma treatments.
Dr. Mondello’s postdoctoral work at Weill Cornell focused on epigenetic therapies, particularly HDAC3 inhibitors, while her research at Mayo Clinic led to new risk models for follicular lymphoma. She now leads clinical trials, including those investigating HDAC3 inhibitors combined with venetoclax.
Her goal is to become an independent investigator, integrating clinical practice and research to improve B-cell lymphoma treatment outcomes.